NDC Package 68071-2547-5 Ondansetron

Ondansetron Hydrochloride Solution Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
68071-2547-5
Package Description:
50 mL in 1 BOTTLE, PLASTIC
Product Code:
Proprietary Name:
Ondansetron
Non-Proprietary Name:
Ondansetron Hydrochloride
Substance Name:
Ondansetron Hydrochloride
Usage Information:
Ondansetron oral solution, USP is indicated for the prevention of nausea and vomiting associated with:highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2initial and repeat courses of moderately emetogenic cancer chemotherapyradiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomenOndansetron oral solution, USP is also indicated for the prevention of postoperative nausea and/or vomiting.
11-Digit NDC Billing Format:
68071254705
NDC to RxNorm Crosswalk:
  • RxCUI: 312085 - ondansetron HCl 4 MG in 5 mL Oral Solution
  • RxCUI: 312085 - ondansetron 0.8 MG/ML Oral Solution
  • RxCUI: 312085 - ondansetron (as ondansetron HCl dihydrate) 4 MG per 5 ML Oral Solution
  • RxCUI: 312085 - ondansetron 4 MG per 5 ML Oral Solution
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Nucare Pharmaceuticals,inc.
    Dosage Form:
    Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Sample Package:
    No
    FDA Application Number:
    ANDA091342
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    01-27-2011
    End Marketing Date:
    11-30-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 68071-2547-5?

    The NDC Packaged Code 68071-2547-5 is assigned to a package of 50 ml in 1 bottle, plastic of Ondansetron, a human prescription drug labeled by Nucare Pharmaceuticals,inc.. The product's dosage form is solution and is administered via oral form.

    Is NDC 68071-2547 included in the NDC Directory?

    Yes, Ondansetron with product code 68071-2547 is active and included in the NDC Directory. The product was first marketed by Nucare Pharmaceuticals,inc. on January 27, 2011.

    What is the 11-digit format for NDC 68071-2547-5?

    The 11-digit format is 68071254705. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-168071-2547-55-4-268071-2547-05